Publication | Open Access

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

Metastatic Breast CancerOncologyAntitumor ActivityLow-dose Oral MethotrexateBreast OncologyMedicineBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation Oncology